U.S. oncology company IPO money raised 2006-2022
This graph shows the amount of money which emerging R&D stage oncology companies in the U.S. raised through initial public offerings from 2006 to 2022. During 2021, such oncology companies in the U.S. raised nearly seven billion dollars by going public, the highest amount in the provided period.